KLRB1 and central nervous system cancer: CD161 blockers have been reported to effectively enhance the T cell‐mediated killing of glioma cells and significantly improve antitumor function.[46] GO analyses were performed to investigate the possible biological functions and associated signaling pathways of each T cell subpopulation.